Kidney Cancer Diagnostics and Therapeutics Market OCT2016 | Page 5

Global Kidney Cancer Diagnostics and Therapeutics Market 6.5.2 Middle-East 6.5.3 Africa 7. Pipeline Product Analysis 7.1 Overview 7.2 Pipeline Development Landscape 7.3 Molecular Targets in the Pipeline 7.4 Clinical Trials 7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target 7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target 7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target. Enquire more about the report at http://www.marketdataforecast.com/market-reports/globalkidney-cancer-diagnostics-and-therapeutics-market-843/inquire 8.Strategic Analysis 8.1 PESTLE analysis 8.1.1 Political 8.1.2 Economic 8.1.3 Social 8.1.4 Technological 8.1.5 Legal 8.1.6 Environmental 8.2 Porter’s Five analysis 8.2.1 Bargaining Power of Suppliers 8.2.2 Bargaining Power of Consumers 8.2.3 Threat of New Entrants 8.2.4 Threat of Substitute Products and Services 8.2.5 Competitive Rivalry within the Industry 9.Market Leaders' Analysis 9.1 GlaxoSmithKline 9.1.1 Overview 9.1.2 Product Analysis 9.1.3 Strategic Evaluation and Operations [phone] | www.marketdataforecast.com | [email protected]